Focal segmental glomerulosclerosis historical perspective: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Focal segmental glomerulosclerosis}} | {{Focal segmental glomerulosclerosis}} | ||
{{CMG}}{{APM}} {{AE}} {{MKK}} {{OO}} | {{CMG}}, {{APM}}; {{AE}} {{MKK}}, {{OO}} | ||
==Overview== | ==Overview== | ||
[[Focal segmental glomerulosclerosis]] (FSGS) was | [[Focal segmental glomerulosclerosis]] (FSGS) was discovered by Theodor Fahr, a German [[pathologist]], in 1925, and he referred to it as "[[lipoid nephrosis]] with [[degeneration]]", showing a clear association to [[minimal change disease]]. In 1957, FSGS was then described by Dr. Arnold Rich, a pathologist at Johns Hopkins University. | ||
==Historical Perspective== | ==Historical Perspective== | ||
Revision as of 14:33, 1 August 2018
|
Focal segmental glomerulosclerosis Microchapters |
|
Differentiating Focal segmental glomerulosclerosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Focal segmental glomerulosclerosis historical perspective On the Web |
|
American Roentgen Ray Society Images of Focal segmental glomerulosclerosis historical perspective |
|
FDA on Focal segmental glomerulosclerosis historical perspective |
|
CDC on Focal segmental glomerulosclerosis historical perspective |
|
Focal segmental glomerulosclerosis historical perspective in the news |
|
Blogs on Focal segmental glomerulosclerosis historical perspective |
|
Directions to Hospitals Treating Focal segmental glomerulosclerosis |
|
Risk calculators and risk factors for Focal segmental glomerulosclerosis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [3], Olufunmilola Olubukola M.D.[4]
Overview
Focal segmental glomerulosclerosis (FSGS) was discovered by Theodor Fahr, a German pathologist, in 1925, and he referred to it as "lipoid nephrosis with degeneration", showing a clear association to minimal change disease. In 1957, FSGS was then described by Dr. Arnold Rich, a pathologist at Johns Hopkins University.
Historical Perspective
Discovery
- Focal segmental glomerulosclerosis (FSGS) was first discovered by a Theodor Fahr, a German pathologist, in 1925, and he referred to it as "lipoid nephrosis with degeneration", showing a clear association to minimal change disease.[1]
- In 1957, FSGS was then described by Dr. Arnold Rich, a pathologist at Johns Hopkins University.[2]
- In 1970, Jacob Churg and colleagues finally classified FSGS as a unique renal glomerulopathy in the " Pathology of the Nephrotic Syndrome in Children: Report for the International International Study of Kidney Disease in Children" in view of its clinical and pathological features, and its steroid-resistance in comparison to minimal change disease.[3]
References
- ↑ Fahr, T (1925). Pathologische anatomie des morbus brightii. In: Fahr T, Gruber GB, Koch M, et al. eds. Harnorgane Männliche Geschlechtsorgane. Vienna: Springer. pp. 156–472.
- ↑ RICH AR (1957). "A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis". Bull Johns Hopkins Hosp. 100 (4): 173–86. PMID 13426687.
- ↑ Churg J, Habib R, White RH (1970). "Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children". Lancet. 760 (1): 1299–302. PMID 4193942.